A new test may help detect bladder cancer in dogs well before any symptoms begin to appear. The test, formally known as the CADETSM BRAF Mutation Detection Assay, can be used to analyze urine for traces of cells shed by urothelial, or transitional cell, carcinomas. Developed by Sentinel Biomedical, the test is being made available for purchase by the American Kennel Club.
The test’s ability to detect cancer in its earlier stages opens up additional treatment options — and the improved outcomes that come with them — for dogs affected by the disease.
“There are an estimated 80,000 canine TCC/UC cases diagnosed each year—most are diagnosed in later stages, when the cancer is more advanced and treatment options are limited. We have created a reliable and proactive screening tool for dog owners and breeders that will allow more time to create an optimal treatment plan, thereby potentially extending the life of their dogs.”
— Matthew Breen, PhD CBiol FRSB, Founder, Sentinel Biomedical
The test is being sold in two forms: a screening test and a diagnostic test. The screening version is available to consumers through the AKC’s online store while the diagnostic kit is available to veterinary practitioners through Sentinel Biomedical’s online store.